AMPLY Discovery leverages evolution and machine learning to discover new drugs through technology that digitizes biological diversity using next-generation sequencing.

AMPLY Discovery

Massive Bioinformatics provides bioinformatics and biotechnology solutions aimed at enhancing the quality of life through innovative products and services, self-described as a team of dedicated scientists and software engineers.

Massive Bioinformatics

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Twist Bioscience Corporation Common Stock

Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. 

Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, industrial chemicals and data storage, scientists use our synthetic genes, oligo pools, and NGS target enrichment to better lives and improve the sustainability of the planet. 

Twist Bioscience is uniquely positioned to help accelerate these efforts by providing precision at a scale that is otherwise unavailable. Our technology overcomes inefficiencies and enables cost-effective, rapid, precise, high-throughput DNA synthesis and sequencing. We offer both the quality and quantity researchers need now to rapidly realize opportunities ahead. 

Twitter          @TwistBioscience
Facebook     facebook.com/TwistBioscience
YouTube       youtube.com/TwistBioscience

#WeMakeDNA

Capital World Investors

Kangmei Pharmaceutical

NFT Investment

Reinet Investments S.C.A.

Biomatics Capital Partners

Ditch Plains Capital Management LP

3W Partners

Bay City Capital

Dentsu Ventures

Asset Management Ventures (AMV)

E Squared Capital Management

Twist Bioscience

🧬 If you read one “look back” piece this time of year, this is certainly the one you should read. By Emily Leproust: A 10 Year Leap That Has Changed The World.

Twist Bioscience, #NGS, #DataStorage, #TwistBlog, #DNA

We have a treat for you! Aaron Sato’s talk from #ANTIBODYENG: “Writing the Future of Biologics with an Integrated Offering of Immunization, Libraries, & Machine Learning” including super interesting case studies. Check it out: https://lnkd.in/gHeGp9Ci

#antibody #antibodydiscovery #DNA #machinelearning

Don't miss this opportunity to accelerate your experiments with Twist Bioscience’s new Express Genes service! Unlock the door to limitless possibilities and propel your genetic research forward.

Order your Express Genes before capacity runs out: https://lnkd.in/gKR4i9fX

#gene #genes #DNA

Our miniaturization process allows us to write DNA more sustainably than traditional 96 well plate methods. A LOT more…

Learn more here: bit.ly/3QZzkjP

Twist Bioscience, #ESG, #DNA, #gene

Twisters across all sites have been gathering together to celebrate the holidays, end of year, and each other. Our South San Francisco, Wilsonville, and Carlsbad teams had a great time last week dressing up for a night out with snacks, drinks, friends and colleagues!

Wishing you a joyful holiday season and happy New Year! 🎁 🥂

Metric
Company Name	AMPLY Discovery	Massive Bioinformatics
Symbol
MSH ID	COM:AMPLYDISCOVERY	COM:MASSIVEBIOINFORMATICS
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Biotechnology	Biotechnology
Country	GB	TR
Stage
Employee Count	7
Website	amplydiscovery.com	massivebioinformatics.com
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	9.97
28-Day Growth Score	6.64
90-Day Growth Score	6.30
365-Day Growth Score	34.06

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:TWISTBIOSCIENCE

Twist Bioscience

Last Close

41.66

22/11 21:00

Market Cap

2.51B

Beta: -

Volume Today

716.37K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue